VANCOUVER, BC / ACCESSWIRE / October 1, 2014 / Auxellence Health Corporation (CSE:AID) today announces a Pioneer Edition of TULIP(TM), a novel online system for general health care. Orders for 80 units will be open today, only for selected buyers from Canada and Europe, and will cost $500 per year. Sydney Au, CEO, noted that this initial edition is in preparation for a larger commercial release on December 1, 2014.
Sydney Au, CEO
Auxellence Health Corporation
Email: [email protected]
Phone: (604) 780-3311
About Auxellence Health Corporation (CSE:AID)
Auxellence is a technology company engaged in the provision of biomedical online services for common health problems. The company offers an extensive platform for physiologically interactive computing supporting therapeutic-diagnostic (theranostic) devices, expert systems, and recommender applications for personal health management. The initial focus is on weight management and skin conditions.
Disclaimer for Forward-Looking Information
Statements in this press release regarding the Company which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as "may", "will", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to factors. The Company does not intend to update any changes to such statements, except as required by law. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
SOURCE: Auxellence Health Corporation